The Crohn's disease–ulcerative colitis clinical appraisal update: emerging trends in clinical practice by Sandborn, W, Colombel, J, D'Haens, G, Ghosh, S, Panaccione, R, Panés, J, Travis, S, Peyrin-Biroulet, L

Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies. by Sandborn, W, Danese, S, D'Haens, G, Moro, L, Jones, R, Bagin, R, Huang, M, David Ballard, E, Masure, J, Travis, S

A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. by Gasche, C, Scholmerich, J, Brynskov, J, D'Haens, G, Hanauer, S, Irvine, E, Jewell, D, Rachmilewitz, D, Sachar, D, Sandborn, W, Sutherland, L

Biosimilars in IBD: hope or expectation? by Gecse, K, Khanna, R, van den Brink, G, Ponsioen, C, Löwenberg, M, Jairath, V, Travis, S, Sandborn, W, Feagan, BG, D'Haens, G

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study. by Travis, S, Danese, S, Kupcinskas, L, Alexeeva, O, D'Haens, G, Gibson, P, Moro, L, Jones, R, Ballard, E, Masure, J, Rossini, M, Sandborn, W

Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease. by D'Haens, G, Fedorak, R, Lémann, M, Feagan, BG, Kamm, M, Cosnes, J, Rutgeerts, P, Marteau, P, Travis, S, Schölmerich, J, Hanauer, S, Sandborn, W

Budesonide MMX® for the induction of remission of mild to moderate ulcerative colitis: a pooled safety analysis. by Lichtenstein, G, Travis, S, Danese, S, D'Haens, G, Moro, L, Jones, R, Huang, M, Ballard, E, Bagin, R, Hardiman, Y, Collazo, R, Sandborn, W

Evolving concepts in phases I and II drug development for Crohn's Disease by Jairath, V, Levesque, BG, Casteele, N, Khanna, R, Mosli, M, Hindryckx, P, Travis, S, Duijvestein, M, Rimola, J, Panes, J, D'Haens, G, Sandborn, WJ, Feagan, BG

Review article: defining remission in ulcerative colitis. by Travis, S, Higgins, P, Orchard, T, Van Der Woude, C, Panaccione, R, Bitton, A, O'Morain, C, Panés, J, Sturm, A, Reinisch, W, Kamm, M, D'Haens, G

European evidence-based Consensus on the management of ulcerative colitis: Current management. by Travis, S, Stange, E, Lémann, M, Oresland, T, Bemelman, W, Chowers, Y, Colombel, J, D'Haens, G, Ghosh, S, Marteau, P, Kruis, W, Mortensen, N, Penninckx, F, Gassull, M

Lymphoma risk and overall safety profile of Adalimumab in patients with Crohn's disease with up to 6 years of follow-up in the pyramid by D'Haens, G, Reinisch, W, Panaccione, R, Satsangi, J, Petersson, J, Petersson, J, Arikan, D, Perotti, E, Robinson, A, Kalabic, J, Alperovich, G, Thakkar, R, Loftus, E

Evolving concepts in Phase I and II Drug Development for Crohn's Disease. by Jairath, V, Levesque, B, Vande Casteele, N, Khanna, R, Mosli, M, Hindryckx, P, Travis, S, Duijvenstein, M, Rimola, J, Panes, J, D'Haens, G, Sandborn, W, Feagan, B

Development of red flags index for early referral of adults with symptoms and signs suggestive of Crohn’s disease: an IOIBD initiative by Danese, S, Fiorino, G, Mary, J, Lakatos, P, D’Haens, G, Moja, L, D’Hoore, A, Panes, J, Reinisch, W, Sandborn, W, Travis, S, Vermeire, S, Peyrin-Biroulet, L, Colombel, J

Biomarker correlation with endoscopic outcomes in patients with Crohn's disease: data from CALM by Reinisch, W, Panaccione, R, Bossuyt, P, Baert, F, Armuzzi, A, Travis, S, Danese, S, Sandborn, W, D'Haens, G, Berg, S, Maa, J, Petersson, J, Neimark, E, Robinson, A, Colombel, J

Benzimidazoles promote anti-TNF mediated induction of regulatory macrophages and enhance therapeutic efficacy in a murine model by Wildenberg, M, Levin, A, Ceroni, A, Guo, Z, Koelink, P, Hakvoort, T, Westera, L, Bloemendaal, F, Brandse, J, Simmons, A, D'Haens, G, Ebner, D, van den Brink, G

Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial by Panaccione, R, Colombel, J, Travis, S, Bossuyt, P, Baert, F, Vaňásek, T, Danalıoğlu, A, Novacek, G, Armuzzi, A, Reinisch, W, Johnson, S, Buessing, M, Neimark, E, Petersson, J, Lee, W, D'Haens, G

Diagnostic accuracy of endoscopic trimodal imaging and chromoendoscopy for lesion characterization in ulcerative colitis by Vleugels, JLA, Rutter, MD, Ragunath, K, Rees, CJ, Ponsioen, CY, Lahiff, C, Ket, SN, Wanders, LK, Samuel, S, Butt, F, Kuiper, T, Travis, SPL, D'Haens, G, Wang, LM, Van Eeden, S, East, JE, Dekker, E

Chromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis (FIND-UC): an international, multicentre, randomised contro... by Vleugels, JLA, Rutter, MD, Ragunath, K, Rees, CJ, Ponsioen, CY, Lahiff, C, Ket, SN, Wanders, LK, Samuel, S, Butt, F, Kuiper, T, Travis, SPL, D'Haens, G, Wang, LM, van Eeden, S, East, JE, Dekker, E

European evidence based consensus on the diagnosis and management of Crohn's disease: current management. by Travis, S, Stange, E, Lémann, M, Oresland, T, Chowers, Y, Forbes, A, D'Haens, G, Kitis, G, Cortot, A, Prantera, C, Marteau, P, Colombel, J, Gionchetti, P, Bouhnik, Y, Tiret, E, Kroesen, J, Starlinger, M, Mortensen, N

Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process. by Peyrin-Biroulet, L, Billioud, V, D'Haens, G, Panaccione, R, Feagan, B, Panés, J, Danese, S, Schreiber, S, Ogata, H, Hibi, T, Higgins, P, Beaugerie, L, Chowers, Y, Louis, E, Steinwurz, F, Reinisch, W, Rutgeerts, P, Colombel, J, Travis, S, Sandborn, W